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httpsWHAT THIS PAPER ADDS
This international analysis assesses current trends and variations in the treatment of ruptured abdominal aortic
aneurysms. The report indicates that outcomes after open repair of ruptured abdominal aortic aneurysms are
better at centres with high volumes, while a substantial number of ruptured repairs are carried out at low
volume centres. Hospitals that have a primary EVAR strategy for ruptures have an improved peri-operative
mortality. This real world evidence could provide benchmarks for vascular surgery centres in their consider-
ations of centralisation and implementation of endovascular aortic repair.Objectives: Current management of ruptured abdominal aortic aneurysms (RAAA) varies among centres and
countries, particularly in the degree of implementation of endovascular aneurysm repair (EVAR) and levels of
vascular surgery centralisation. This study assesses these variations and the impact they have on outcomes.
Materials and methods: RAAA repairs from vascular surgical registries in 11 countries, 2010e2013, were
investigated. Data were analysed overall, per country, per treatment modality (EVAR or open aortic repair [OAR]),
centre volume (quintiles IV), and whether centres were predominantly EVAR (50% of RAAA performed with
EVAR [EVAR(p)]) or predominantly OAR [OAR(p)]. Primary outcome was peri-operative mortality. Data are
presented as either mean values or percentages with 95% CI within parentheses, and compared with chi-square
tests, as well as with adjusted OR.
Results: There were 9273 patients included. Mean age was 74.7 (74.5e74.9) years, and 82.7% of patients were
men (81.9e83.6). Mean AAA diameter at rupture was 7.6 cm (7.5e7.6). Of these aneurysms, 10.7% (10.0e11.4)
were less than 5.5 cm. EVAR was performed in 23.1% (22.3e24.0). There were 6817 procedures performed in
OAR(p) centres and 1217 performed in EVAR(p) centres. Overall peri-operative mortality was 28.8% (27.9e29.8).
Peri-operative mortality for OAR was 32.1% (31.0e33.2) and for EVAR 17.9% (16.3e19.6), p < .001, and
the adjusted OR was 0.38 (0.31e0.47), p < .001. The peri-operative mortality was 23.0% in EVAR(p) centres
(20.6e25.4), 29.7% in OAR(p) centres (28.6e30.8), p < .001; adjusted OR ¼ 0.60 (0.46e0.78), p < .001. Peri-
operative mortality was lower in the highest volume centres (QI > 22 repairs per year), 23.3% (21.2e25.4) than
in QII-V, 30.0% (28.9e31.1), p < .001. Peri-operative mortality after OAR was lower in high volume centres
compared with the other centres, 25.3% (23.0e27.6) and 34.0% (32.7e35.4), respectively, p < .001. There was
no signiﬁcant difference in peri-operative mortality after EVAR between centres based on volume.rresponding author. Department of Surgical Sciences, Vascular Surgery, Uppsala University, Uppsala, Sweden.
il address: jacobudt@rm.dk (Jacob Budtz-Lilly).
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182 Jacob Budtz-Lilly et al.Conclusions: Peri-operative mortality is lower in centres with a primary EVAR approach or with high case volume.
Most repairs, however, are still performed in low volume centres and in centres with a primary OAR strategy.
Reorganisation of acute vascular surgical services may improve outcomes of RAAA repair.
 2018 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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The mortality following repair of ruptured abdominal aortic
aneurysm (RAAA) remains high, despite improvements in 30
day mortality, recently reported at around 30e35%.1e5 The
possible reasons for this improvement over time include
better peri-operative and post-operative care, and the
technological impact of endovascular aneurysm repair
(EVAR).6e8 It has been documented that the minimal
invasiveness of EVAR reduces the morbidity and 30 day
mortality of intact AAA treatment, particularly as the pro-
cedure can often be performed under local anaesthesia.9e11
Indeed, EVAR is increasingly being used as the treatment
modality of choice for intact AAAs in many countries. The
rates for treating RAAA are still lagging, although they have
reached as high as 40e50% in the United States and
Australia.12
Several trials, including the recent Immediate Manage-
ment of Patients with Ruptured Aneurysm: Open Versus
Endovascular Repair (IMPROVE) trial, have aimed to assess
the superiority of EVAR over open aortic repair (OAR) for
ruptures.4,13,14 As summarised in the meta-analysis by
Sweeting et al., there was no difference in survival at 90
days, although women appear to beneﬁt from an endovas-
cular strategy.15 However, the long-term results from the
IMPROVE trial now reveal that an endovascular strategy of-
fers improved survival at 3 years at a lower cost and a better
quality of life, with no differences in the number of re-in-
terventions.16 Whether or not these results reﬂect general
practice can be assessed in multinational vascular surgery
databases, as their evaluation can shed light on real world
differences in care and outcomes.17 The objective of the
present study is to report the variations in treatment and
outcomes for patients with RAAA from 11 countries over 4
years.MATERIALS AND METHODS
The Vascunet collaboration
Vascunet is an international collaboration of registries, con-
sisting of national (Australia, Denmark, Hungary, Iceland,
New Zealand, Norway, Sweden, Switzerland, UK), regional
(Finland), and multi-centre (Germany) databases. The
completeness of the participating registries was >90% for
RAAA procedures performed in Denmark, Hungary, Iceland,
Sweden, and Finland, 80% in New Zealand and Norway, and
68% in Australia.18e21 The ascertainment rate in the UK was
estimated at 73% for 2012e2014, but is uncertain for the 2
previous years.22 The Swiss database includes patients
operated for AAA in 129 public hospitals and representsapproximately 85% of all open and 70% of all EVAR proced-
ures in the country. The German data are based on approx-
imately 130 certiﬁed vascular centres participating in the
German Society for Vascular Surgery. A recent report by the
same collaboration has documented outcomes following
treatment of intact AAAs from the same database.23Study design
Data on ruptured AAA repairs were collected from vascular
registries for the 4-year period 2010e2013 from 11 coun-
tries. These were analysed overall, per country, per treat-
ment modality (EVAR or OAR), for centre volume (divided
into quintiles), and for centres that were either predomi-
nantly EVAR (50% of RAAA repairs performed with EVAR;
EVAR(p)) or predominantly OAR (OAR(p)).Outcomes and variables
The primary outcome was peri-operative mortality, deﬁned
as either in hospital death (registries from Australia, Ger-
many, Hungary, New Zealand, Norway, Switzerland, and
United Kingdom) or death within 30 days of surgery (reg-
istries from Denmark, Finland, Iceland, and Sweden). Pa-
tients were also registered to a single hospital centre
identiﬁcation number. The covariates included for analysis
were: age, gender, AAA diameter (cm), and the presence or
absence of the following comorbidities: ischaemic heart
disease, pulmonary disease, diabetes mellitus, and cere-
brovascular disease.
The numbers (proportions) of missing data were as fol-
lows: peri-operative mortality, 47 (0.5%); age, 339 (3.6%);
gender, 1232 (13.2%); hospital centre identiﬁcation number,
1266 (13.6%); operative technique, 0 (0%); AAA diameter,
2013 (21.6%); ischaemic heart disease, 252 (2.7%); pulmo-
nary disease, 1927 (20.7%); diabetes mellitus, 1405 (15.1%);
cerebrovascular disease, 3313 (35.5%).Statistical analysis
Continuous data are presented with mean values and 95%
CIs, and compared with t tests. Rates are presented as
percentages with 95% CIs. Missing data were handled by
exclusion. Comparison of rates was performed using the
chi-square test. Logistic regression models were performed
to estimate the OR for peri-operative mortality for the
included covariates. To correct for multiple testing, a p value
of <.01 was regarded as signiﬁcant. Finally, funnel plots
were created using upper and lower CI (95% and 99.8%)
from the calculated mean peri-operative mortalities, where
Impact of Centralisation and Endovascular Aneurysm Repair 183values from each centre are displayed in the form of a
scatter plot.
Volume per centre was determined by placing the partici-
pating centres into descending order, based on the average
number of procedures for the 4 year period: Five quintiles (QI,
highest volume e QV, lowest volume) were formed.
All data analysis was carried out using R Statistical Software
Package (R Foundation for Statistical Computing, Vienna,
Austria) and SPSS for Mac, Version 24.0 (SPSS Inc., Armonk,
NY, USA: IBM Corp.).
RESULTS
There were 9273 patients with ruptured abdominal aortic
aneurysms available for analysis. These represented 16.0%
(15.7e16.3) of the total number of AAAs operated on
during this period, ranging from 10.3% (9.8e11.8) in Ger-
many to 29.4% (25.9e32.9) in Finland. The overall mean
number of patients per treatment centre was 4.9 per year,
ranging from 2.3 in Germany to 26.7 in Denmark (Table 1).
The mean age was 74.7 years (74.5e74.9), and the majority
of patients were men (82.7%, CI 81.9e83.6). EVAR was
performed for 23.1% (22.3e24.0) of all RAAA procedures.
The mean AAA size at the time of operation was 7.6 cm
(7.5e7.6), 7.7 cm (7.7e7.8) for men and 6.9 cm (6.8e7.0)
for women. Of these aneurysms, 10.7% (10.0e11.4) were
less than 5.5 cm with 8.7% (7.9e9.4) in men, and 17.1%
(14.9e19.2) in women.Table 1. Characteristics of ruptured AAAs for the 11 participating Vasc
Number of
cases (%)
RAAAs vs. total
AAA repairs, % (95% CI)
Mean n
of patie
centre p
Total 9320 16.0 (15.7e16.3) 4.9
Australia 1444 (15.5) 18.6 (17.8e19.5) 4.2
Denmark 748 (8.0) 25.0 (23.5e26.6) 26.7
Finland 192 (2.1) 29.4 (25.9e32.9) 16.0
Germany 1444 (15.5) 10.3 (9.8e10.8) 2.3
Hungary 187 (2.0) 18.0 (15.7e20.4) 2.4
Iceland 21 (0.2) 21.7 (13.3e30.0) 21.0
New Zealand 220 (2.4) 15.3 (13.5e17.2) n/a
Norway 334 (3.6) 13.8 (12.4e15.1) n/a
Sweden 1038 (11.1) 21.1 (19.9e22.2) 8.4
Switzerland 342 (3.7) 13.6 (12.3e14.9) 5.0
United Kingdom 3350 (35.9) 16.5 (16.0e17.0) 6.7
RAAA ¼ ruptured abdominal aortic aneurysm; AAA ¼ abdominal aor
available.
Table 2. Comparison of RAAA patient characteristics and como
EVAR
Mean age, years (95% CI) 76.5 (76.1e
Women, % (95% CI) 18.4 (16.6e
Mean AAA diameter, cm (95% CI) 7.1 (7.0e7
Ischaemic heart disease, % (95% CI) 41.6 (39.5e
Pulmonary disease, % (95% CI) 22.9 (20.7e
Diabetes mellitus, % (95% CI) 11.9 (10.3e
Cerebrovascular disease, % (95% CI) 6.7 (5.2e8
RAAA ¼ ruptured abdominal aortic aneurysm; EVAR ¼ end
AAA ¼ abdominal aortic aneurysm.Comparisons of characteristics and comorbidities be-
tween EVAR and OAR patients are given in Table 2. EVAR
patients were slightly older (76.5 vs. 74.1 years, p < .001)
and had greater rates of ischaemic heart and pulmonary
disease, while OAR patients had larger aneurysms (7.7 vs.
7.1 cm, p < .001) at presentation. Almost all the registries
lack data on neck diameter and length, as well as angulation
(but those variables have recently been added to most of
the registries).
The overall peri-operative mortality was 28.8% (27.9e
29.8). For female patients, it was higher: 32.3% (29.9e
34.9), compared with male patients, 27.1% (26.1e28.2),
p < .0001 (Fig. 1). After adjusting for age, AAA diameter,
and the above mentioned comorbidities, the peri-operative
mortality OR revealed no statistical difference between men
and women, OR 1.03 (.86e1.23), p ¼ .78.
Peri-operative mortality was 32.1% (31.0e33.2) for OAR
and 17.9% (16.3e19.6) for EVAR, p < .0001. Data for each
country and procedure are given in Table 3. The adjusted
peri-operative mortality OR for EVAR against OAR was .38
(0.31e0.47), p < .001.
Peri-operative mortality was lower in EVAR(p) centres
(23.0%, 95% CI 20.6e25.4) compared with OAR(p) centres
(29.7%, 95% CI 28.6e30.8), p < .001 (Table 4). A sensitivity
analysis was performed, revising the percentage of RAAA
patients treated by EVAR for EVAR(p) to 40%; the peri-
operative mortality was 20.2% (16.6e23.9) for EVAR(p)unet countries for 2010e2013.
umber
nts per
er year
Mean age,
years (95% CI)
Mean AAA
diameter, cm
(95% CI)
EVAR, % (95% CI)
74.7 (74.5e74.9) 7.6 (7.5e7.6) 23.1 (22.2e24.0)
74.4 (73.9e74.9) 7.2 (7.1e7.2) 39.8 (37.2e42.3)
72.7 (72.1e73.2) n/a 5.1 (3.5e6.7)
73.3 (72.0e74.7) 7.8 (7.5e8.0) 9.9 (5.6e14.2)
74.6 (74.1e75.1) 7.2 (7.0e7.3) 31.2 (28.8e33.6)
71.3 (69.9e72.6) 7.7 (7.4e8.0) 7.5 (3.7e11.3)
72.3 (71.0e74$2) 7.8 (7.0e8.6) 19.1 (7.3e37.4)
74.5 (73.3e75.7) 7.5 (7.3e7.7) 10.9 (6.8e15.1)
n/a 7.5 (7.3e7.7) 11.7 (8.2e15.1)
75.2 (74.8e75.7) 7.6 (7.5e7.8) 29.3 (26.5e32.1)
72.5 (71.5e73.5) 7.6 (7.1e8.1) 24.9 (20.3e29.5)
75.7 (75.4e75.9) 7.9 (7.9e8.0) 18.0 (16.7e19.3)
tic aneurysm; EVAR ¼ endovascular aneurysm repair; n/a ¼ not
rbidities for EVAR and OAR.
OAR p
76.9) 74.1 (73.9e74.4) <.001
20.2) 16.9 (16.0e17.9) .15
.2) 7.7 (7.7e7.8) <.001
43.8) 28.2 (27.2e29.3) <.001
25.0) 16.6 (15.6e17.5) <.001
13.4) 11.0 (10.2e11.8) .30
.2) 6.6 (5.9e7.3) .95
ovascular aneurysm repair; OAR ¼ open aortic repair;
Figure 1. Peri-operative mortality after ruptured AAA repair overall, as well as based on operative technique and gender.
Table 3. Overall and per procedure peri-operative RAAA mortality rates for participating Vascunet countries for 2010e2013.
Number of EVAR/open
repairs (% EVAR)
Overall mortality,
% (95% CI)
EVAR mortality,
% (95% CI)
OAR mortality,
% (95% CI)
Total 2155/7165 (23.1) 28.8 (27.9e29.8) 17.9 (16.3e19.6) 32.1 (31.0e33.2)
Australia 574/870 (39.8) 18.4 (16.4e20.4) 9.2 (6.9e11.6) 24.5 (21.6e27.4)
Denmark 38/710 (5.1) 25.1 (22.0e28.3) 10.5 (0.3e20.8) 25.9 (22.7e29.2)
Finland 19/173 (9.9) 23.7 (17.7e29.8) a 26.3 (19.7e33.0)
Germany 450/994 (31.2) 35.5 (33.1e38.0) 24.2 (20.3e28.3) 40.6 (37.6e43.7)
Hungary 14/173 (7.5) 33.2 (26.4e40.0) 7.1 (0e22.6) 35.3 (28.1e42.5)
Iceland 4/17 (19.0) 19.1 (7.3e37.4) a 23.5 (1.1e46.0)
New Zealand 24/196 (10.9) 28.2 (22.2e34.2) 16.7 (0.6e32.7) 29.6 (23.2e36.0)
Norway 39/295 (11.7) 21.3 (16.9e25.7) 15.4 (3.5e27.2) 22.0 (17.3e26.8)
Sweden 304/734 (29.3) 29.6 (26.8e32.4) 23.4 (18.6e28.1) 32.2 (28.8e35.5)
Switzerland 85/257 (24.9) 22.8 (18.3e27.3) 19.1 (10.5e27.6) 24.0 (18.7e29.3)
United Kingdom 604/2746 (18.0) 32.6 (31.0e34.2) 20.3 (17.0e23.5) 35.3 (33.5e37.1)
RAAA ¼ ruptured abdominal aortic aneurysm; EVAR ¼ endovascular aneurysm repair; OAR ¼ open aortic repair.
a There were no deaths in these cohorts, thus limiting the 95% CI.
184 Jacob Budtz-Lilly et al.centres and 34.0% (31.3e36.7) for OAR(p) centres,
p < .001. For EVAR procedures speciﬁcally, there was no
signiﬁcant difference in peri-operative mortality between
EVAR(p) (17.9%) and OAR(p) (16.9%), p ¼ .56. Nor was
there a signiﬁcant difference among those patients who
underwent OAR (EVAR(p), 32.1%, OAR(p), 32.1%, p ¼ .99).
The OR for peri-operative mortality was signiﬁcantly lower
for EVAR(p) centres, OR 0.60 (0.46e0.78), p < .001.The
detailed logistic regression is provided as a supplementary
table. Of the centres with an EVAR(p) strategy for RAAA
repair, 95.4% (90.0e100.0) used a strategy of EVAR(p) for
elective AAA repair, whereas only 58.2% (53.2e63.3) of the
OAR(p) centres for RAAA repair used an EVAR(p) strategy
for elective AAA repair, p < .001. More speciﬁcally, 82.0%
(77.2e86.8) of the EVAR(p) elective patients were treated
by EVAR, while 50.7% (47.8e53.6) of the OAR(p) elective
patients were treated by EVAR, p < .001.23
There were 442 participating centres, of which 66 were
EVAR(p) treatment centres (Table 5). Of the 13 highest
volume centres (QI, >22 repairs per year), none were
EVAR(p). The greatest percentage of EVAR (30.6%) was
performed in QII. Peri-operative mortality was lower in thehighest volume centres, 23.3% (21.2e25.4), p < .001. Peri-
operative mortality for OAR was signiﬁcantly lower in the
high volume centres compared with the other centres,
25.3% (23.0e27.6) and 34.0% (32.7e35.4), respectively,
p < .001. Despite the variation in peri-operative mortality in
EVAR between quintiles, there was no statistical differences
between them, p ¼ .07.
The relationship between centre volume and peri-
operative mortality is graphically demonstrated in the
form of a bubble graft and funnel plots for both EVAR and
OAR over 4 years (Figs. 2 and 3) with mean peri-operative
mortality as the target value.DISCUSSION
This large, multinational registry based analysis of RAAA
repair activity indicates that although the use of EVAR in
treating RAAAs has increased since the previous Vascunet
report in 2011,24 23.1% vs. 11.7%, signiﬁcant variations in
clinical practice, centralisation, and outcome remain. The
study indicates that improved outcome is coupled with a
primary EVAR strategy for treatment of ruptures, as well as
Table 4. Comparison of RAAA peri-operative mortalities for primary EVAR and primary OAR centres, 2010e2013.
Primary EVAR centres Primary OAR centres p
Number of procedures 1217 6816
Women, % (95% CI) 18.0 (15.7e20.3) 16.9 (16.0e17.9) .40
EVAR, % (number EVAR/OAR) 63.8 (777/440) 15.8 (1076/5740) <.001
Overall peri-operative mortality, % (95% CI) 23.0 (20.6e25.4) 29.7 (28.6e30.8) <.001
EVAR peri-operative mortality, % (95% CI) 17.9 (15.2e20.6) 16.9 (14.6e19.1) .56
OAR peri-operative mortality, % (95% CI) 32.1 (27.7e36.5) 32.1 (30.9e33.3) .99
RAAA ¼ ruptured abdominal aortic aneurysm; EVAR ¼ endovascular aneurysm repair; OAR ¼ open aortic repair.
Table 5. Peri-operative mortalities, overall and per primary strategy, for quintiles of centres, abased on mean number of procedures per
hospital, 2010e2013.
Total QI QII QIII QIV QV
Number of centres 442 13 25 40 68 296
Number of centres,
EVAR as primary
treatment
66 0 7 5 11 43
Mean number of
procedures per
hospital per year
4.5 >22 12e22 8e12 4e8 1e4
EVAR, % (95% CI) 23.1 (22.3e24.0) 14.4 (12.6e16.1) 30.6 (28.4e32.8) 26.0 (23.9e28.2) 21.4 (19.4e23.4) 22.5 (20.5e24.6)
Overall peri-operative
mortality (95% CI)
28.8 (27.9e29.8) 23.3 (21.2e25.4) 29.3 (27.1e31.5) 27.9 (25.7e30.1) 30.2 (27.9e32.4) 32.7 (30.4e35.0)
OAR peri-operative
mortality (95% CI)
32.1 (31.0e33.2) 25.3 (23.0e27.6) 33.5 (30.8e36.3) 32.0 (29.3e34.7) 33.7 (31.0e36.3) 36.8 (34.1e39.5)
EVAR peri-operative
mortality (95% CI)
17.9 (16.3e19.6) 11.2 (7.0e15.3) 19.7 (16.2e23.2) 16.4 (12.8e19.9) 17.3 (13.3e21.3) 18.8 (14.8e22.9)
Q ¼ quintile; EVAR ¼ endovascular aneurysm repair; OAR ¼ open aortic repair.
a All centres were placed in descending order, based on the mean number of procedures performed over 4 years. Quintiles were formed
based on the number of patients treated per quintile in this rank ordering.
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open surgery is used. These ﬁndings may have a bearing on
the organisation of acute vascular surgical services.
Patient selection, both in terms of haemodynamic and
anatomical stability, has an impact on the choice of treatment
and, likewise, on the outcome.25,26 The patients offered EVAR
in this cohort were older and sicker, while no data are avail-
able regarding anatomical constraints, including neck length,
width, or angulation. It is interesting to note however, that
OAR patients had larger AAA diameters, which is known to
render aortas less amenable to treatment by EVAR, as well as
to poorer outcomes overall.27e29 Although turn down rate is
not assessed in the current database, the fact that patients
treated by EVAR are older and bear a greater degree of
comorbidities implies that, to some extent, EVAR is used in
patients who are otherwise not regarded as optimal open
repair candidates.
The implementation and expansion of access to EVAR
have led some centres to use EVAR as the treatment of
choice for RAAAs. The decision to analyse EVAR(p) against
OAR(p) centres was therefore deliberate, as a measure
against potential patient selection bias. As seen in Table 4,
the peri-operative mortality for EVAR(p) centres was
signiﬁcantly lower than it was for OAR(p) centres, and this
remained true in a logistic regression correcting for age,
gender, and comorbidities. This is despite the similar peri-
operative mortality rates for EVAR and OAR separately ineach group. Thus the EVAR(p) centres have better results
merely as a result of the greater use of EVAR.
The volume outcome relationship in AAA treatment has
been well addressed.30,31 In their analysis of the Nationwide
Inpatient Sample database, for example, McPhee et al.
found that the volume of AAA repairs, both intact and
ruptured, is predictive of mortality for RAAA treatment.
Much of this is explained by the number of open repairs
performed. This was similarly shown in a previous Vascunet
report on intact repairs, in which worsening mortality for
OAR was largely a result of worsening results in low volume
centres.23 The data in Table 5 reﬂect this as well, where
lower peri-operative mortalities for both OAR and EVAR
were associated with high volume centres and, more spe-
ciﬁcally, high OAR volume centres.
Although the relationship between volume and OAR ap-
pears strong, the impact of volume on peri-operative out-
comes after EVAR is less clear. Zettervall et al. found a strong
association between hospital and surgeon volume for open
AAA repair and peri-operative mortality but, in contrast no
association with EVAR.32 Indeed, the funnel plots in Fig. 3
illustrate that an increase in volume is associated with
improved peri-operative mortality for open repair, whereas
this is not true for volumes of EVAR.The differences between
quintiles for EVAR patients were not statistically signiﬁcant
(p ¼ .07), and although the number of patients was sub-
stantial, a type II statistical error cannot be excluded.
Figure 2. Bubble chart depicting the overall peri-operative mor-
tality and the percentage of EVAR per centre on the x and y axis,
respectively, while the size of each bubble represents the relative
number of patients treated at each centre for 2010e2013.
Figure 3. Funnel plot of total volume, 2010e2013, versus peri-operativem
EVAR. The interrupted lines represent the 95% and 99.8% CI. The target
186 Jacob Budtz-Lilly et al.It is interesting to note the variation in the care of RAAA
patients between countries. The relationship between
operation volume, operating technique, and outcome is
complex, and it affects country level peri-operative mor-
tality in different ways. Two examples of this are Denmark,
which had the highest degree of centralisation (>25 RAAAs
per centre, per year), the lowest rates of EVAR (5.1%), and
yet the overall peri-operative mortality (25.1%) is in the
middle of the group. In contrast, the Australian vascular
surgery services are less centralised (<5 RAAAs per centre,
per year), and almost 40% of patients were treated by
EVAR. Geography, and more speciﬁc population densities,
may have a major inﬂuence on these tendencies. The na-
tional variations in peri-operative outcome may also be
related to differences in case mix and turn down rate for
ruptured AAA repair, which could not be assessed in the
current dataset. Other factors such as transfer time, health
service funding and the availability of appropriate facilities
also play a role.ortality after ruptured AAA repair with (A) open aortic repair and (B)
is the mean peri-operative mortality and is shown by the red line.
Impact of Centralisation and Endovascular Aneurysm Repair 187The guidelines from the European Society of Vascular
Surgery state that AAA repair should only be performed in
hospitals performing at least 50 elective infrarenal AAA
repairs per annum.33 They also add that the organisational
process for implementing appropriate endovascular man-
agement of RAAAs is complex and is one of the drawbacks
preventing its extensive dissemination. It does appear clear,
however, that EVAR(p) centres use EVAR to a greater degree
for their intact AAA repair than OAR(p) centres. The fact
that the majority of OAR(p) centres (58.2%) primarily treat
their elective patients with EVAR perhaps reﬂects some of
the organisational challenges in providing EVAR in the acute
setting.
In regards to the positive association of outcomes with
centres with high volume, the transfer of a patient to a high
volume institution with greater EVAR expertise may seem
prudent, yet Mell et al. showed that the gain in expertise
was negated by the transfer process itself.34 The provision
of vascular services and referral patterns is also affected by
healthcare reimbursement and funding, which varies among
the countries included in the current registry collabora-
tion.12 The landscape of AAA repair is changing however,
and more centres are acquiring competency and experience
ofEVAR as a primary strategy. The process of vascular sur-
gical service reorganisation is complex, and reports are
relatively scarce.35
There are, of course, several other important underlying
issues coupled with centralisation and access to EVAR. The
results presented here do not include patients not treated
(who suffer an almost 100% mortality), and how this is
related to access to vascular surgery. Furthermore, as seen
in Table 1, the percentage of ruptures vs. all AAA repairs,
varies signiﬁcantly among countries. This may be related to
screening programmes, as well as to decisions of when to
treat patients with an intact AAA. Karthikesalingam et al.
touched on this in their recent analysis, suggesting that the
reduced rate of ruptures in the United States may be
related to a lower diameter threshold when treating intact
AAAs.36 Although the mean AAA rupture size in the present
analysis was 7.6 cm, 10.7% were less than 5.5 cm at the
time of rupture. Centralisation and EVAR may offer advan-
tages in treating RAAAs, but the prevention of rupture
should still be the mainstay of treating AAA.Limitations
This analysis of prospectively registered data is vulnerable to
random and systematic missing data, as well as incorrectly
coded data. Aside from random missing data, it should be
noted that Norway and New Zealand had no data regarding
hospital centre identiﬁcation number, thus limiting input from
their 554 patients included. Not all registries achieved na-
tional coverage for ruptured AAA repairs. Generally, centres
participating in the registry collaboration include all the cases
treated in the unit, reducing the risk of case selection in
outcome analysis. Asmentioned above, reporting of RAAAs in
the UK was not mandatory during the study period, thus
exposing the data to selection bias. Some of the participatingregistries have undergone both external and internal valida-
tion,18e20 and those results showed excellent validity, but not
all the participating registries were validated. There is an
ongoing process, however, in which all the registries partici-
pating in the Vascunet collaboration will undergo indepen-
dent international validation.
There are other variables not reported, which could have
impacted on treatment and outcomes. There are, for
example, no data regarding the means of diagnosis at the
time of operation. This could certainly have some inﬂuence
on the percentage of patients reported with an aneurysm
less than 5.5 cm. Furthermore, data regarding the haemo-
dynamic stability of the patients are also lacking. This could
have impacted decisions as to whether the patient under-
went EVAR or open repair and, ultimately, peri-operative
mortality. Missing data and the bias of patient selection
are incontrovertible limitations of a retrospective analysis,
but ones that are hopefully mitigated by such a large and
international patient cohort.
CONCLUSION
Despite the growing proportion of EVAR used for intact
AAA, OAR still predominates as the treatment used in the
majority of RAAA repairs, even in the highest volume cen-
tres. Peri-operative mortality is lower in centres that either
have high volumes or apply a primary EVAR strategy for
treatment of ruptures; however, most patients are operated
on at small centres and with open repair. These ﬁndings
may impact the future organisation of acute vascular sur-
gical services.
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